Home › Funds › BAKER BROS. ADVISORS LP › RLAY

BAKER BROS. ADVISORS LP position in RLAY

RELAY THERAPEUTICS INC COM · Health Care

BAKER BROS. ADVISORS LP reported holding 2,826,783 shares of RLAY (RELAY THERAPEUTICS INC COM) in its Q2 2026 13F filing — a position valued at US$52.9M, representing 0.28% of its reported portfolio and ranking #35 among its reported holdings. BAKER BROS. ADVISORS LP has disclosed RLAY holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)2.83M sh
Reported value held$52.89M
Portfolio Weight0.28%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BAKER BROS. ADVISORS LP's RLAY position evolved

BAKER BROS. ADVISORS LP first disclosed a stake in RLAY in Q3 2023 at 1,160,117 shares (US$9.8M). The position peaked in Q2 2026 at 2,826,783 shares, worth US$52.9M. Across 12 filings, BAKER BROS. ADVISORS LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 10 time(s). The most recent filing (Q2 2026) shows 2,826,783 shares valued at US$52.9M — an increase of 1,666,666 shares quarter over quarter.. Notable position changes include a 144% increase in Q2 2026 (shares fell 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.16M $9.76M New
Q4 2023 1.16M $12.77M Hold
Q1 2024 1.16M $9.63M Hold
Q2 2024 1.16M $7.56M Hold
Q3 2024 1.16M $8.21M Hold
Q4 2024 1.16M $4.78M Hold
Q1 2025 1.16M $3.04M Hold
Q2 2025 1.16M $4.01M Hold
Q3 2025 1.16M $6.06M Hold
Q4 2025 1.16M $9.81M Hold
Q1 2026 1.16M $11.54M Hold
Q2 2026 2.83M $52.89M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RLAY and 13F data

RLAY (RELAY THERAPEUTICS INC COM) is a Health Care company. 64 other funds we track also report a position in RLAY — the largest reported positions include SB INVESTMENT ADVISERS (UK) LTD (US$522.1M), Casdin Capital (US$300.0M), PERCEPTIVE ADVISORS LLC (US$263.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RLAY

All RLAY fund holders →

FAQ

How long has BAKER BROS. ADVISORS LP held RLAY?

BAKER BROS. ADVISORS LP has disclosed RLAY holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is BAKER BROS. ADVISORS LP's current position in RLAY?

As of Q2 2026, BAKER BROS. ADVISORS LP holds 2.83M shares of RLAY (RELAY THERAPEUTICS INC COM), valued at $52.89M, representing 0.28% of its reported portfolio and ranking #35.

Has BAKER BROS. ADVISORS LP been buying or selling RLAY?

In the latest 13F filing (Q2 2026), BAKER BROS. ADVISORS LP increased its position in RLAY. The position peaked in Q2 2026 at 2.83M shares.

Which other funds hold RLAY?

Other major institutional holders of RLAY include SB INVESTMENT ADVISERS (UK) LTD, Casdin Capital, PERCEPTIVE ADVISORS LLC, among 64 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.